Targeting mutant p53 in human tumors.

Lehmann BD, Pietenpol JA
J Clin Oncol. 2012 30 (29): 3648-50

PMID: 22965952 · DOI:10.1200/JCO.2012.44.0412

MeSH Terms (16)

Antineoplastic Agents Disease-Free Survival Female Humans Male Molecular Targeted Therapy Mutation Neoplasms Patient Safety Quinuclidines Risk Assessment Sensitivity and Specificity Signal Transduction Survival Analysis Treatment Outcome Tumor Suppressor Protein p53

Connections (4)

This publication is referenced by other Labnodes entities:

Links